Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Aaltonen R. |
The Role of Human Ureaplasmas in Spontaneous Preterm Birth.
|
2 |
Aaltonen R et al. |
Ureaplasma urealyticum:no independent role in the pathogenesis of bronchopulmonary dysplasia.
|
3 |
Aittokallio J et al. |
Non-invasive respiratory monitoring during wakefulness and sleep in pre- ja and postmenopausal women.
|
4 |
Alhola P et al. |
Estrogen therapy and cognition: a 6-year single-blind follow-up study in postmenopausal women.
|
5 |
Brady BM et al. |
A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive.
|
6 |
Eigeliene N et al. |
Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures.
|
7 |
Erkkola R. |
The Menopause.
|
8 |
Erkkola R. |
Raskauspahoinvointi ja hyperemeesi.
|
9 |
Erkkola R. |
Recent advances in contraception.
|
10 |
Grénman S, Auranen A. |
Gynekologisten syöpien leikkaushoidon keskittäminen Suomessa.
|
11 |
Grénman S et al. |
A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: The Finnish Ovarian Cancer (FINOVA) study.
|
12 |
Hou L-H et al. |
Therapeutic effects of Jinqi Jiangtang Tablet on women with polycystic ovary syndrome (in Chinese).
|
13 |
Jokimaa V. |
Koeputkihedelmöityshoitojen välittömät komplikaatiot.
|
14 |
Järvenpää J et al. |
Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in Nothern Finland .
|
15 |
Kalleinen N et al. |
Sleep deprivation and hormone therapy in postmenopausal women.
|
16 |
Karakorpi M et al. |
Hormone treatment gives no benefit against cognitive changes caused by acute sleep deprivation in postmenopausal women.
|
17 |
Kiilholma P et al. |
Naisten virtsankarkailun hoito.
|
18 |
Koivusalo R. |
HPV E6-p53 Interaction - a Target for Therapeutic Approaches in Cervical Cancer.
|
19 |
Koivusalo R et al. |
Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists.
|
20 |
Kumpulainen S et al. |
Surgical treatment of ovarian cancer in different hospital categories - A prospective nation-wide study in Finland.
|
21 |
Kurvinen K et al. |
Radiation-induced effects on telomerase in gynecological cancer cell lines with different radiosensitivity and repair capacity.
|
22 |
Laurikainen E. |
Tension-free Vaginal Procedures for Female Stress Urinary Incontinence.
|
23 |
Laurikainen E, Kiilholma P. |
A nationwide analysis of transvaginal tape release for urinary retention after tension-free vaginal tape procedure.
|
24 |
Morin-papunen L, Palo P. |
Gynekologinen alavatsakipu.
|
25 |
Mäenpää JU et al. |
Sequential gemcitabine-carboplatin followed by paclitaxel-carboplatin in the first-line treatment of advanced ovarian cancer: A phase II study.
|
26 |
Mäkinen J. |
Naisen virtsainkontinenssi.
|
27 |
Mäkinen J. |
Gynekologiset laskeumat.
|
28 |
Mäkinen J. |
Kohdunulkoinen raskaus.
|
29 |
Nieminen P et al. |
Kohdunkaulan, emättimen ja ulkosynnytinten solumuutokset - diagnostiikka, hoito ja seuranta.
|
30 |
Nieminen P et al. |
Vauhdittuuko kohdunkaulan syövän torjunta?
|
31 |
Palo P. |
Gynekologiset kaikututkimukset.
|
32 |
Polo-Kantola P. |
Management of sleep disorders during menopause.
|
33 |
Polo-Kantola P. |
Sleep disturbance during menopause.
|
34 |
Rintala M et al. |
Natural history of oral papillomavirus infections in spouses: A prospective Finnish HPV Family Study.
|
35 |
Rintala M et al. |
Detection of high-risk HPV DNA in semen-response.
|
36 |
Saaresranta T et al. |
Menopausal estrogen therapy predicts better nocturnal oxyhemoglobin saturation.
|
37 |
Salmi T, Grenman S. |
Hormonihoidon aloitus, seuranta ja lopetus.
|
38 |
Saraste M et al. |
Cerebrospinal fluid findings in multiple sclerosis patients before, during and after pregnancy.
|
39 |
Tanner L et al. |
Hazards associated with pregnancies and deliveries in lysinuric protein intolerance.
|